Literature DB >> 2736430

Nasal provocation with histamine in allergic rhinitis patients: clinical significance and reproducibility.

R G van Wijk1, P G Mulder, P H Dieges.   

Abstract

In a selected group of rhinitis patients (n = 12) with an IgE-mediated allergy to house dust mites, the nasal response to insufflation of histamine chloride appeared to be related to symptom scores obtained from the patients. In contrast to the sum of the nasal airway resistances (NAR) induced by all doses of histamine, the total amount of secretion and total number of sneezes could be predicted from clinical scores. The reproducibility of the nasal provocation test was tested by comparison of the test results in two sessions with a 1-week interval. The correlation between both sessions was highest with respect to nasal secretion (r = 0.87; P less than 0.001) and the number of sneezes (r = 0.76; P = 0.004). The correlation coefficient was 0.71 (P = 0.01) when the nasal airway resistance was used in the assessment of nasal response. A good reproducibility of the nasal provocation test was also obtained using an end-point titration method and determining the concentration required to produce 0.5 ml secretion and/or five sneezes as the end-point (r = 0.76; P = 0.004). The concentration required to double nasal airway resistance yielded a correlation coefficient of 0.56 (P = 0.052). We conclude that the clinical significance of nasal provocation with histamine increases when, besides nasal airway resistance, the amount of secretion and the number of sneezes is used in the assessment of the nasal response.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2736430     DOI: 10.1111/j.1365-2222.1989.tb02386.x

Source DB:  PubMed          Journal:  Clin Exp Allergy        ISSN: 0954-7894            Impact factor:   5.018


  4 in total

1.  An evaluation of short-term corticosteroid response in perennial allergic rhinitis using histamine and adenosine monophosphate nasal challenge.

Authors:  Andrew M Wilson; Erika J Sims; Linda C Orr; Fiona Robb; Brian J Lipworth
Journal:  Br J Clin Pharmacol       Date:  2003-04       Impact factor: 4.335

2.  Efficacy and tolerability comparison of ebastine 10 and 20mg with loratadine 10mg: a double-blind, randomised study in patients with perennial allergic rhinitis.

Authors:  R J Davies
Journal:  Clin Drug Investig       Date:  1998       Impact factor: 2.859

3.  Nasal hyperreactivity and inflammation in allergic rhinitis.

Authors:  I M Garrelds; C de G Veld; R G Wijk; F J Zijlstra
Journal:  Mediators Inflamm       Date:  1996       Impact factor: 4.711

4.  Nasal histamine responses in nonallergic rhinitis with eosinophilic syndrome.

Authors:  Giampietro Zambetti; Andrea Ciofalo; Raffaello Romeo; Pietro Soldo; Massimo Fusconi; Antonio Greco; Giuseppe Magliulo; Marco de Vincentiis
Journal:  Allergy Rhinol (Providence)       Date:  2015-01
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.